CRIS Current Research Information System

GIONCHETTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.117
AS - Asia 13.705
EU - Europa 9.787
AF - Africa 913
SA - Sud America 894
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 39.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.877
SG - Singapore 3.723
VN - Vietnam 3.700
CN - Cina 3.289
GB - Regno Unito 2.010
IT - Italia 1.970
DE - Germania 1.221
SE - Svezia 1.058
HK - Hong Kong 1.000
FR - Francia 703
BR - Brasile 652
IN - India 587
RU - Federazione Russa 574
UA - Ucraina 449
IE - Irlanda 410
KR - Corea 344
FI - Finlandia 322
NL - Olanda 283
JP - Giappone 274
ZA - Sudafrica 221
CI - Costa d'Avorio 207
TG - Togo 174
SC - Seychelles 163
CH - Svizzera 144
BG - Bulgaria 138
EE - Estonia 130
JO - Giordania 120
AR - Argentina 114
CA - Canada 98
PH - Filippine 98
BE - Belgio 74
BD - Bangladesh 70
PL - Polonia 66
IQ - Iraq 64
ID - Indonesia 63
TH - Thailandia 59
ES - Italia 57
AT - Austria 54
MX - Messico 52
TW - Taiwan 43
TR - Turchia 41
HN - Honduras 38
GR - Grecia 33
IR - Iran 32
EC - Ecuador 30
NG - Nigeria 29
SA - Arabia Saudita 28
CD - Congo 27
PK - Pakistan 27
UZ - Uzbekistan 27
CL - Cile 25
CO - Colombia 23
PY - Paraguay 19
AU - Australia 17
BZ - Belize 17
EG - Egitto 16
KZ - Kazakistan 16
LT - Lituania 15
RO - Romania 15
VE - Venezuela 15
CZ - Repubblica Ceca 14
KE - Kenya 14
TN - Tunisia 13
AZ - Azerbaigian 12
HR - Croazia 12
AE - Emirati Arabi Uniti 11
LB - Libano 11
MA - Marocco 11
MY - Malesia 11
ET - Etiopia 10
DZ - Algeria 9
BH - Bahrain 8
JM - Giamaica 8
BO - Bolivia 7
PS - Palestinian Territory 7
AL - Albania 6
DO - Repubblica Dominicana 6
IL - Israele 6
PE - Perù 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
DK - Danimarca 4
MN - Mongolia 4
NP - Nepal 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AO - Angola 3
KG - Kirghizistan 3
NO - Norvegia 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
BN - Brunei Darussalam 2
BW - Botswana 2
CY - Cipro 2
KW - Kuwait 2
Totale 39.394
Salva come PNG Salva come JPEG
Città #
Singapore 2.537
Southend 1.642
Ashburn 1.584
Fairfield 1.282
Chandler 1.042
Hong Kong 949
Ho Chi Minh City 825
Hanoi 716
Hefei 708
San Jose 697
Santa Clara 651
Woodbridge 616
Seattle 540
Wilmington 538
Houston 535
Princeton 514
Dong Ket 444
Beijing 427
Cambridge 419
Dublin 409
Bologna 394
Ann Arbor 353
Boardman 319
Lauterbourg 297
Seoul 292
Helsinki 273
Jacksonville 245
Tokyo 229
Los Angeles 215
Abidjan 207
Nanjing 201
New York 176
Lomé 174
Westminster 174
Berlin 168
Milan 155
Padova 153
Frankfurt am Main 140
Sofia 133
Buffalo 125
Bern 121
Amman 120
Council Bluffs 117
Da Nang 116
Haiphong 110
San Diego 106
Dallas 103
Guangzhou 89
Redondo Beach 87
Bengaluru 80
Jinan 80
Shenyang 80
Turin 77
Rome 76
Saint Petersburg 76
Changsha 70
São Paulo 68
Brescia 65
Johannesburg 62
Phoenix 62
Hebei 60
Munich 60
Nuremberg 55
Shanghai 54
Brussels 52
London 52
Mülheim 51
Yubileyny 51
Nanchang 50
Redwood City 50
Washington 50
Chicago 49
Falkenstein 48
Orem 44
Medford 42
Redmond 42
Bremen 41
Montreal 40
Tianjin 40
Hải Dương 39
Warsaw 38
Florence 37
Dearborn 36
Quận Bình Thạnh 36
Atlanta 35
Des Moines 34
Henderson 34
Jiaxing 34
Thái Nguyên 34
Falls Church 33
Zhengzhou 33
Lappeenranta 32
Amsterdam 31
Biên Hòa 31
Hangzhou 30
Mahé 29
Olalla 29
Baghdad 28
Brooklyn 26
Centro 26
Totale 24.879
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 656
Ulcerative Colitis 356
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 342
COVID-19 in IBD: The experience of a single tertiary IBD center 299
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 297
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 266
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment 253
Adult attachment and early parental experiences in patients with Crohn’s Disease 250
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 243
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 240
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 239
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 238
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 238
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 236
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 234
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 233
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 229
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 221
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 220
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 216
Adalimumab in active ulcerative colitis: a "real-life" observational study. 215
Medical treatment and management of severe ulcerative colitis 215
Infliximab in the treatment of Crohn's disease 212
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 212
Attachment and quality of life in patients with inflammatory bowel disease 210
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 208
High-dose probiotics for the treatment of active pouchitis 204
Influence of steroid treatment's duration in patients with active Crohn's disease 203
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 202
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 199
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 197
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 196
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 196
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 195
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 195
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 194
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 192
Clinical course of microscopic colitis in a single-center cohort study 192
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 191
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 190
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 190
Implications of antioxidant enzymes in human gastric neoplasms 189
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 187
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 187
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 187
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 186
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 186
Antibiotics and probiotics in treatment of inflammatory bowel disease 186
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. 185
Management and treatment of distal ulcerative colitis 185
Implications of the westernized diet in the onset and progression of IBD 184
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 182
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 181
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 181
Oral budesonide in the treatment of chronic refractory pouchitis. 180
Role of conventional therapies in the era of biological treatment in Crohn's disease. 179
Clinical guidelines for the management of pouchitis 178
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 178
Review article: aminosalicylates for distal colitis 177
Parental Bonding and Inflammatory Bowel Disease 177
Management of inflammatory bowel disease: does rifaximin offer any promises 176
Probiotics in IBD: A critical review 176
Post COVID-19 irritable bowel syndrome 175
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 175
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 175
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 174
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 174
Role of Biologics in refractory pouchitis 174
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 173
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. 173
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 171
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 170
The role of Budesonide-MMX in active ulcerative colitis. 170
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 170
Percutaneous abdomino-pelvic abscess drainage in complicated Crohn’s disease 169
Antimicrobials in the management of inflammatory bowel disease 168
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease 168
MANAGEMENT OF POUCHITIS 168
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 167
Which therapies are advisable in pouchitis? 165
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 165
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 164
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 163
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 163
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 162
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 161
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 161
Problematic proctitis and distal colitis 161
Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients 160
Pre-pouch ileitis 160
Sympathetic hyperactivity in patients with ulcerative colitis. 160
Randomized controlled trials in pouchitis 160
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 160
Oral beclomethasone dipropionate in chronic refractory pouchitis 159
A current overview of corticosteroid use in active ulcerative colitis 158
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 158
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 157
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 156
Totale 19.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.212 0 0 0 0 0 0 0 0 0 244 120 848
2021/20224.114 431 114 247 182 332 178 98 227 331 293 1.079 602
2022/20234.892 505 745 248 551 319 387 141 286 898 141 340 331
2023/20241.530 107 237 137 111 125 358 78 91 40 110 60 76
2024/20255.994 296 834 478 382 929 305 447 208 142 408 318 1.247
2025/202613.974 1.385 1.564 1.335 1.084 1.580 936 1.594 530 2.964 1.002 0 0
Totale 40.367